PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Alleviated hormone imbalance and insulin resistance while improving ovarian pathology in rat models [PMID:37489849]
Ameliorated renal fibrosis in rats via the PI3K/Akt pathway [PMID:40056634]
Pectin polysaccharide (RCHP-S) reduced enteritis symptoms in DSS-induced colitis mice by inhibiting inflammatory factors [PMID:35571944]
Pectic polysaccharide (RCP-2-3) reduced postprandial serum triglyceride accumulation and weight gain in mice [PMID:40441837]
Rubusoside mitigated neuroinflammation and cellular apoptosis in mice and cell lines [PMID:38237261]
Flower extract showed growth impeding effects against multidrug-resistant E. coli, S. aureus, and K. pneumoniae [PMID:37654834]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36698464 (2022) — Bioactive components, pharmacological effects, and drug development of traditional herbal medicine Rubus chingii Hu (Fu-Pen-Zi). · Frontiers in nutrition
- 2.PMID: 31379574 (2019) — Rubus chingii Hu: A Review of the Phytochemistry and Pharmacology. · Frontiers in pharmacology
- 3.PMID: 32503732 (2020) — Rubus chingii Hu: an overview of botany, traditional uses, phytochemistry, and pharmacology. · Chinese journal of natural medicines
- 4.PMID: 39072206 (2024) — Chemical composition, pharmacological activity and development strategies of Rubus chingii: A review. · Chinese herbal medicines
- 5.PMID: 38621934 (2024) — [Comparative analysis of plastomes of Rubus chingii and R. chingii var. suavissimus].